Axol Bioscience and Censo Biotechnologies Announce Merger
Axol Bioscience and Censo Biotechnologies Announce Merger 03/17/2021 | 05:27am EDT Send by mail : Message : iPSC industry-leaders combine tools, talent, and technologies to drive life science discovery forward Merger accompanied by £3.8million ($5.3m USD) investment across shareholders, which will be used to fund recruitment and growth of the business Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterization services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies, today announced that the two companies ...